In 2020, the spread of Covid-19 crisis accelerated the global demand for hyperinflation systems tremendously due to high weightage given to health, well-being and safety. The sales went up exponentially in 2020 encouraging the key players to make investments in research and development projects for ensuring advanced offerings in 2021.
Key Developments in Hyperinflation System Market
Eminent players like Mercury Medical, Bay Medical, Teleflex Medical Incorporation, Becton Dickinson, Smiths Medical and Vyaire Medical Incorporation are undertaking joint ventures, partnership agreements, research & developments, collaborations, mergers & acquisitions etc as their prime strategies to combat the rising competition.
Westmed, Mercury Medical and SunMed, B Braun and Hospira Group are among the key players focusing on delivering innovative launches to ensure better equipments enabling faster recovery in the Covid-19 crisis.
For instance, Smiths Medical Corporation, a leading medical device manufacturer announced the introduction of its new hyperinflation system called ‘ EchoGlo’ peripheral nerve block portfolio on 14th December, 2020. This recent addition to the Portex portfolio of pain management products offers customers a complete solution for regional anesthesia from pump to patient.
The Portex EchoGlo needle has been engineered for echogenic brightness under ultrasound even at extreme angles, which can enhance visualization and accuracy in delivering medication. The technology is helping the clinicians to confidently place local anesthetics reducing post-operativedependency on opioids.
The company has combined the echogenic brightness of EchoGlo products with CADD pump portfolio to provide a safe and effective solution to both the clinicians and patients. Portex EchoGlo needles are in high demand in United States, Mexico and Canada in 2021.
In addition to Smiths Medical, Vyaire Medical Corporation launched ‘SuperNO2VA’ , a nasal PAP ventillation device on April 2020 to deal with the respiratory problems. The ventillation device is designed to connect to an oxygen supply source and use gas flow and resistance to generate positive pressure to support patients in respiratory insufficiency or failure. SuperNO2VA is used to pre-oxygenate, maintain ventillation, rescue ventillation and relieve upper airway obstruction due to decreased level of consciousness.
It combines a no-leak nasal mask with an anesthesia hyperinflation bag, an adjustable pressure-limiting (APL) valve and is connection ready for wall oxygen or an oxygen tank source. The device is acting as a boon to treat the patients by reducing the risk of re-breathing CO2 , ensuring oxygen flows greater than 8 LPM and over-pressurization among the patients. The demand of this ‘SuperNO2VA’ ventillation is rising throughout the world due to rising need to treat the Covid patients in 2021.
Evolution of Hyperinflation Systems
Hyperinflation system market is expected to remain influenced with growing number of premature births across the globe. According to WHO, mortality rates associated with premature births is projected to increase, particularly among developing nations as compared to developed economies.
For instance, in the India alone, around 3,519, 100 babies are born prematurely in 2017. This has pushed the need for hyperinflation system in a bid to facilitate efficient breathing and reduce mortality rates.
This aspect coupled with increasing adolescent pregnancy worldwide is likely to trigger the need and demand for efficient breathing systems such as a hyperinflation system. UNICEF and WHO have revealed that the mortality rate due to adolescent pregnancy is expected to rise in the coming years, which is expected to complement the sales of hyperinflation system, in turn pushing their demand and growth of the hyperinflation system market in the forthcoming years.
Another aspect pushing the demand for hyperinflation system are the increasing number of NICUs (Neonatal Intensive Care Units) worldwide. With growing number of NICUs worldwide, hyperinflation system manufacturers can expect steady stream of opportunities with respect to adoption and demand for hyperinflation system in the forthcoming years.
Manufacturers of hyperinflation system can focus on investing in emerging economies such as India owing to rising demand for hyperinflation system across NICUs in the country along with increasing NICU capacity. For instance, NICU bed capacity in Pune (India) is expected to increase to accommodate 67 beds in one unit in the coming years. This factor is likely to remain instrumental in driving demand for hyperinflation system, in turn supplementing hyperinflation system market growth.
Hyperinflation system is a medical devices used for breathing assistance. Hyperinflation of lung is generally used for secretion removal and to improve lung compliance. Chance of lung atelectasis occurrence increases in anaesthetized patient on 100% oxygen ventilation via hyperinflation system hence, oxygenated air or only air is preferred in hyperinflation system. Hyperinflation system comes with oxygen reservoirs (inflated O2 bags, corrugated tubing) and safety components (integrated pressure manometer, filters, pop-off valves and peep valves).
Hyperinflation system is mainly used for providing the infants with oxygen support in preterm births, emergency cases, hypoxia, and other conditions such as Asthma, Chronic obstructive pulmonary disease (COPD), etc. Decreased lung capacity, decreased alveolar capacity, narrowing of airways, non-developed lungs (in case of preterm births) are some of the conditions where hyperinflation system is used to offer enhanced patient care and treatment.
Prevalence of the chronic obstructive pulmonary disease (COPD) among the geriatric population has significantly contributed towards growth of the global hyperinflation system market.
Drivers and Restraints
Increasing worldwide aging population coupled with increasing prevalence of chronic obstructive pulmonary disease is attributed to global hyperinflation system market growth. Increasing awareness in middle and low income countries about COPD will further drive hyperinflation system market. Increasing prevalence of preterm births globally can further drive hyperinflation system market.
In the emergency cases in hospitals, growing need for breathing assistance and hyperinflation continues to persist for delivering oxygenated air, removing secretions in the lungs, increase the lung capacity, and resulting in improved lung compliance in term driving hyperinflation system market. In addition, smoking has continued to remain a major cause of developing COPD among individuals.
Nearly 73% deaths occur due to COPD and increase in the tobacco smoking, which is expected to fuel the global hyperinflation system market. Affordability of hyperinflation system devices has further contributed towards growth of the global hyperinflation system market. Hyperinflation system operates manually by squeezing air bag to infuse air into the lungs and when bag released air from lungs comes out which makes measuring of air pressure difficult even when manometer is attached, due to tedious process it acts as restraint in hyperinflation system market.
By Indication Type
- Chronic pulmonary obstructive disease (COPD)
- Preterm births
- Ambulatory surgical centers
Global hyperinflation market is expected to witness a steady growth over the forecast period attributed to the increase in the number of COPD cases among old population. By indication type, the chronic pulmonary obstructive disease (COPD) segment is expected to dominate the hyperinflation system market due to increasing prevalence of chronic disease.
By end user type, the hospital segment is expected to represent a leading revenue contributor in the hyperinflation system market due to higher acceptance and availability of effective treatment solutions. Innovative modifications in hyperinflation system are on rise improving accuracy and success of treatment e.g. hyperinflation system attached manometers with peep valve are recent change helping physicians to accurately measure air pressure in lungs.
Hyperinflation system market is mainly dominated by North America attributed to the increasing number of COPD cases globally. Europe is also expected to account for a lucrative share in hyperinflation global market. However, the Asia-Pacific market is expected to emerge a as one of the leading hyperinflation system market over the coming years attributed to developing economies such as India and China. With vast population residing with increasing geriatric population in countries like in India and China Asia-Pacific hyperinflation system market is expected to grow significantly. The Middle East and Africa is expected to remain the least lucrative hyperinflation system market attributed to low adoption of treatment.
Some of the global key players operating in hyperinflation system market are
- Bay Medical
- Smiths Medical
- Mercury Medical
- Westmed, Inc.
- Solutions in Critical Care
- Teleflex Medical, Inc.
- Becton Dickinson & Co
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
- Middle East and Africa (GCC, S. Africa, Rest Of MEA)
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.